Tag Archives: generics

The Pain in Spain

By Guest Blogger | Published: February 16, 2011
The pain of the Spanish drug-spending squeeze extends way beyond the plain, says Reflector. The cries of anguish at Spanish drug-spending squeezes are coming not only from Madrid, but from many of the autonomous regions around the periphery of the country too. After almost a decade of continual disruption and downward pressure on pricing, the medicines industry [...]
Posted in Europe, Global, Guest Blog, Regulatory | Also tagged , , | 2 Comments

Innovators: Take a Leaf from the Generic Industry Book

By Guest Blogger | Published: February 1, 2011
No-one can accuse the European generic industry of indolence. It supplies huge quantities of medicines to European healthcare suppliers — its volume is estimated at around a half of the market. It is accounting for a growing share of marketing authorization applications in Europe. And its industry association, the EGA, has turned it from being [...]
Posted in Europe, Regulatory, healthcare | Also tagged , , , , , , , | Leave a comment

Abbott Shells Out $3.7 Billion for Piramal

By Oriana Schwindt | Published: May 26, 2010
In July 2009, judging solely by total revenue, Abbott was assigned the rank of the eighth-largest pharmaceutical company in the Fortune Global 500. Nearly a year later, the company is looking to move up at least a few notches. On May 21, Abbott acquired Indian generic giant Piramal for a cool $2.12 billion up front, [...]
Posted in Strategy | Also tagged , , , , , , , , | Leave a comment

WHO Threatens Industry Shut-out on Counterfeit Regulation

By William Looney | Published: May 26, 2010
Big Pharma believes that a global generics franchise might give it a softer landing off the patent cliff, but governments that sponsor and regulate the industry are still acting a bit slow on the uptake. The reason? Anti-IP activists are again poisoning the well on global access to medicines, engaging the bigger emerging market governments [...]
Posted in Global | Also tagged , , , , , | Leave a comment

Obama Reveals Healthcare Reform Plan

By Jill Wechsler | Published: February 22, 2010
Image via Wikipedia The health reform proposal unveiled by the White House on Feb. 22, 2010 retains a number of provisions that directly affect drug coverage and industry revenues. The plan highlights that it will close the Medicare drug benefit “doughnut hole” by 2020 to make drugs more affordable to the elderly. Seniors will get some [...]
Posted in News, Regulatory | Also tagged , , , , | 4 Comments